Anaplastic Glioma
📧 Sign up to get email alerts when something new happens for Anaplastic Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-10Clinical Trial Update: HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma [Phase 2]
A Phase 2 trial evaluating HSV G207 with a single radiation dose for children with recurrent high-grade glioma has been withdrawn from Clini…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: gliomasPCV Only in 1p/19q Codeleted Anaplastic Gliomas [Phase 3]
A Phase 3 trial evaluating PCV chemotherapy (procarbazine, lomustine, and vincristine) in patients with Anaplastic glioma with 1p/19q codele…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma [Phase 3]
This is a Phase 3 trial comparing radiation therapy with concomitant and adjuvant temozolomide versus radiation therapy with adjuvant PCV ch…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma [Phase 1]
Phase 1 study of TRIAPINE in combination with temozolomide for recurrent glioblastoma and recurrent gliomas; currently listed as active but …
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas [Phase 1]
Phase 1 trial update for an Anti-GARP CAR-T cell therapy targeting recurrent Grade 2-4 gliomas (including glioblastoma), currently recruitin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/2 study of BGB-290 in combination with temozolomide in patients with recurrent gli…
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM) [Phase 1, Phase 2]
A terminated Phase 1/2 trial evaluating vorinostat, isotretinoin, and temozolomide in adults with recurrent glioblastoma and anaplastic glio…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas.
A completed study evaluating the relationship between molecular phenotype and radiological features on PET and MRI in patients with incident…
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas [Phase 1]
A pediatric Phase 1 trial evaluating selinexor in children with recurrent or refractory solid tumors and high-grade gliomas has completed. R…
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas [Phase 1, Phase 2]
Phase I/II trial evaluating everolimus and sorafenib in recurrent high-grade gliomas has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma [NA]
Clinical trial evaluating MRI assessment of radiation and chemotherapy effects in newly diagnosed glioblastoma multiforme or anaplastic glio…
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma [Phase 2]
Phase 2 trial evaluating Poly-ICLC in recurrent or progressive anaplastic glioma has completed; results posted.
-
CLINICAL_TRIALS withdrawal · 2018-07-19Clinical Trial Update: Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma [Phase 1]
A Phase 1 clinical trial evaluating a nasal spray for recurrent glioblastoma and related gliomas has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma [Phase 2]
Phase 2 trial evaluating temozolomide and carmustine for patients with anaplastic glioma has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-04Clinical Trial Update: Effects of Exercise on Cognitive Function in Glioma Patients [NA]
A completed clinical trial evaluated whether exercise improves cognitive function in patients with low-grade glioma or anaplastic glioma.
-
CLINICAL_TRIALS research · 2015-07-09Clinical Trial Update: Efficacy Study of Radiotherapy Alone Versus CCRT With Temozolomide in Grade III Gliomas Without 1p/19q Codeletion [Phase 2]
Phase 2 trial update comparing radiotherapy alone to concurrent chemoradiotherapy with temozolomide in patients with Grade III gliomas witho…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma [Phase 2]
Phase 2 trial evaluating temozolomide with O6-benzylguanine in temozolomide-resistant malignant glioma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Sunitinib to Treat Recurrent Brain Cancer [Phase 2]
A Phase 2 trial of sunitinib for recurrent brain cancer (glioblastoma, malignant glioma, and anaplastic glioma) was terminated with results …
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma [Phase 1]
Phase 1 trial evaluating temozolomide with O6-benzylguanine in patients with newly diagnosed, recurrent, or progressive anaplastic glioma; t…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas [Phase 1]
A Phase I study of temozolomide combined with O6-benzylguanine and irinotecan in patients with recurrent or progressive cerebral anaplastic …
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: HYPONCO - Hypoxia in Brain Tumors [Phase 2]
This update notes the completion of a Phase 2 trial (HYPONCO) investigating hypoxia in brain tumors in patients with anaplastic glioma.
-
CLINICAL_TRIALS trial_result · 2012-01-11Clinical Trial Update: 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients [Phase 2]
Phase 2 trial assessing a multi-drug regimen including 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine in patients…